Paxil CR
(Paroxetine CR)ApprovedSmall molecule
GSKParoxetine CR is used to treat depression, anxiety disorders, panic disorder, and obsessive-compulsive disorder. It works by helping to balance certain chemicals in the brain that affect mood and emotions.[2] Paxil CR is currently approved and in use across 7 indications[4].[1]
Paxil CR is one of 203 small molecule programs targeting Panic Disorder. It is currently in Approved.
7
Indications
26
Total Trials
0
Active Trials
202
Competitors
Pipeline
Status by Indication[4][1]
Indication
Competition
Competitive Landscape
386 competitors in Major Depressive Disorder
#DrugCompanyPhaseTrials
1Paxil CR
GSKApproved
Elavil
AstraZenecaPhase 3
SAGE-217
BiogenPhase 3
Versed
CConrado Roberto Hoffmann Filho
Phase 3
Quetiapine XR
AstraZenecaPhase 3
ALKS 37
AAlkermes, Inc.
Phase 3
Desvenlafaxine SR
PfizerPhase 3
Seltorexant
Johnson & JohnsonPhase 3
Antidepressant Therapy
AbbViePhase 3
Vraylar
AbbViePhase 3
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Major Depressive Disorder5 trials
Social Anxiety Disorder2 trials
Efficacy and Safety1 trial
Efficacy and Safety of Oxybutynin Versus Paroxetine in Aromatase Inhibitor-induced Vasomotor Symptoms
Unknown status·—·Phase 3·NCT05637671·146 enrolled
Substance Dependence1 trial
Fibromyalgia1 trial
Paroxetine-CR (Paxil-CR) in the Treatment of Patients With Fibromyalgia Syndrome
Completed·—·Phase 4·NCT00610610·120 enrolled
12 more indications
Irritable Bowel Syndrome1 trial
Paroxetine - Controlled Release in the Treatment of Irritable Bowel Syndrome (IBS)
Completed·—·Phase 4·NCT00610909·60 enrolled
Post-Traumatic Stress Disorder1 trial
Fasting Conditions1 trial
MPA1 trial
Effect of Tamsulosin on PE Compared With Paroxetine Hydrochloride
Unknown status·—·Phase 3·NCT03879746·160 enrolled
TIA1 trial
Single Dose1 trial
Panic Disorder1 trial
Unspecified5 trials
Sources
References
- [1]
- [2]MedlinePlus Drug Information — Paxil CR drug information. U.S. National Library of Medicine, National Institutes of Health.
- [3]
- [4]Open Targets Platform — Drug–disease associations for Paroxetine CR. EMBL-EBI & Wellcome Sanger Institute.
- [5]